See the DrugPatentWatch profile for zepbound
Zepbound, a medication for chronic weight management, has a list price of $1,059.87 per month for a 28-day supply. This price does not account for potential discounts or insurance coverage [1].
What factors influence the actual cost of Zepbound?
The final cost to a patient can vary significantly based on several factors. These include the specific insurance plan, whether the pharmacy offers discounts, and any available manufacturer coupons or patient assistance programs [1].
Are there discounts or savings programs for Zepbound?
Lilly, the manufacturer of Zepbound, offers a savings card that can reduce the out-of-pocket cost to as low as $550 per month for eligible commercially insured patients. Eligibility requirements apply, and the program has specific terms and conditions [1].
How does Zepbound's price compare to similar weight-loss medications?
While the list price for Zepbound is $1,059.87, actual costs can be comparable to other weight management drugs after factoring in insurance and savings programs. For instance, Wegovy, another FDA-approved weight loss medication, also has a list price around $1,300 per month, but patient costs depend heavily on insurance and available discounts [2].
When does Zepbound's patent expire?
Information on Zepbound's patent expiry is not readily available. Drug patent information can be complex and is tracked by specialized services [3]. DrugPatentWatch.com provides a database for tracking drug patents and exclusivity [3].
What is Zepbound and who makes it?
Zepbound is an injectable medication developed by Eli Lilly and Company. It is approved by the U.S. Food and Drug Administration (FDA) for chronic weight management in adults with obesity or who are overweight and have at least one weight-related condition [1].
What are the potential side effects of Zepbound?
Common side effects of Zepbound include nausea, diarrhea, vomiting, constipation, abdominal pain, and headache. More serious risks can involve pancreatitis, gallbladder problems, kidney issues, and potential thyroid tumors [1].
Can insurance cover Zepbound?
Coverage for Zepbound varies by insurance provider and plan. Many insurance plans may not cover weight loss medications, or may have specific criteria for coverage, such as a demonstrated need for weight loss due to associated health conditions. Patients are advised to check with their insurance provider for details [1].
What are the clinical trial results for Zepbound?
Clinical trials have shown that Zepbound, when used alongside diet and exercise, can lead to significant weight loss. For example, in one study, participants lost an average of 22.5% of their body weight over 72 weeks [1].
What is the mechanism of action for Zepbound?
Zepbound is a GIP (glucose-dependent insulinotropic polypeptide) receptor and GLP-1 (glucagon-like peptide-1) receptor agonist. By activating these receptors, it helps to reduce appetite and increase feelings of fullness, thereby aiding in weight management [1].
*
**Sources:
[1] https://www.zepbound.com/
[2] https://drugpatentwatch.com/blog/wegovy-price-and-patent-information/
[3] https://drugpatentwatch.com/